在过去的40年里,艾滋病毒治疗模式发生了变化
1Department of Infectious Diseases, Ajou University School of Medicine, Suwon, Korea.
Jugan geon-gang gwa jilbyeong
|January 1, 2026
概括
人类免疫缺陷病毒 (HIV) 治疗已经从致命的疾病演变为可管理的慢性疾病. 现代疗法提供强大的病毒抑制和改善生活质量,标志着艾滋病毒护理的显著范式转变.
科学领域:
- 传染性疾病 传染性疾病
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 人类免疫缺陷病毒 (HIV) 感染在过去40年里发生了变化.
- 最初是一个致命的疾病,艾滋病毒现在是一个慢性可控的疾病.
研究的目的:
- 审查艾滋病毒治疗的历史演变.
- 概述当前的治疗趋势和HIV护理中的范式转变.
主要方法:
- 对艾滋病毒治疗中的关键里程碑进行叙述性回顾.
- 检查从齐多夫丁到高活性抗逆转录病毒疗法 (HAART) 和长效注射剂的治疗方法.
主要成果:
- 1996年采用高活性抗逆转录病毒疗法 (HAART) 降低了艾滋病毒发病率和死亡率.
- 基于整合酶链转移抑制剂 (INSTI) 的疗法可以达到>90%的病毒抑制率.
- "治疗所有"和"不可检测=不可传播" (U=U) 策略增强个人健康和疫情控制.
结论:
- 目前的艾滋病毒治疗侧重于以患者为中心的方法,而不仅仅是病毒抑制.
- 两种药物方案和长效注射剂是新兴趋势.
- 不断发展的治疗方法旨在解决未满足的需求,改善患者的生活质量.
相关概念视频
Retrovirus Life Cycles
49.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.1K
Sexually Transmitted Infections
848
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
848
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
Therapeutic Drug Monitoring: Affecting Factors
170
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
170
Pulmonary Tuberculosis I
801
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
801
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


